| Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 3097 | 2013 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 1979 | 2006 |
| Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015 | 1708 | 2015 |
| Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of oncology 26, v8-v30, 2015 | 1492 | 2015 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1371 | 2006 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1222 | 2016 |
| Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients E De Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ... British journal of cancer 96 (10), 1504-1513, 2007 | 1034 | 2007 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 1025 | 2007 |
| Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ... The Lancet 377 (9769), 914-923, 2011 | 993 | 2011 |
| De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 792 | 2017 |
| 4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4) F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ... Annals of Oncology 29 (8), 1634-1657, 2018 | 791 | 2018 |
| Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of Oncology 30 (8), 1194-1220, 2019 | 721 | 2019 |
| ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ... The Breast 23 (5), 489-502, 2014 | 719 | 2014 |
| 3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3) F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ... The Breast 31, 244-259, 2017 | 694 | 2017 |
| Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ... Annals of oncology 24, vi7-vi23, 2013 | 639 | 2013 |
| Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F Cardoso, N Harbeck, L Fallowfield, S Kyriakides, E Senkus Annals of oncology 23, vii11-vii19, 2012 | 551 | 2012 |
| Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer S Chan, ME Scheulen, S Johnston, K Mross, F Cardoso, C Dittrich, ... Journal of Clinical Oncology 23 (23), 5314-5322, 2005 | 544 | 2005 |
| Clinical application of the 70-gene profile: the MINDACT trial F Cardoso, L Van't Veer, E Rutgers, S Loi, S Mook, MJ Piccart-Gebhart Journal of clinical oncology 26 (5), 729-735, 2008 | 535 | 2008 |
| Pembrolizumab for early triple-negative breast cancer P Schmid, J Cortes, L Pusztai, H McArthur, S Kümmel, J Bergh, C Denkert, ... New England Journal of Medicine 382 (9), 810-821, 2020 | 477 | 2020 |
| High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ... Journal of clinical oncology 27 (34), 5700, 2009 | 470 | 2009 |
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
